Royal Bank of Canada
PROK icon

Royal Bank of Canada’s ProKidney PROK Stock Holding History

Royal Bank of Canada’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Sell
190
-887
-82% -$1.88K ﹤0.01% 7556
2025
Q4 		$2K Sell
1,077
-146,401
-99% -$385K ﹤0.01% 6923
2025
Q3 		$356K Buy
147,478
+27,825
+23% +$74.1K ﹤0.01% 4727
2025
Q2 		$71K Buy
119,653
+112,990
+1,696% +$88K ﹤0.01% 5769
2025
Q1 		$6K Buy
6,663
+302
+5% +$419 ﹤0.01% 6312
2024
Q4 		$11K Sell
6,361
-6,418
-50% -$11.6K ﹤0.01% 6321
2024
Q3 		$24K Buy
12,779
+5,487
+75% +$12.5K ﹤0.01% 6037
2024
Q2 		$18K Buy
7,292
+4,809
+194% +$12.9K ﹤0.01% 6116
2024
Q1 		$5K Sell
2,483
-13,047
-84% -$19.2K ﹤0.01% 6458
2023
Q4 		$27K Buy
15,530
+7,504
+93% +$16.1K ﹤0.01% 6213
2023
Q3 		$37K Buy
8,026
+1,061
+15% +$10.2K ﹤0.01% 5933
2023
Q2 		$78K Buy
6,965
+5,860
+530% +$62.4K ﹤0.01% 5521
2023
Q1 		$12K Buy
1,105
+15
+1% +$160 ﹤0.01% 6238
2022
Q4 		$7K Buy
1,090
+290
+36% +$2.77K ﹤0.01% 6662
2022
Q3 		$7K Hold
800
– – ﹤0.01% 6606
2022
Q2 		$8K Sell
800
-20,000
-96% -$198K ﹤0.01% 6477
2022
Q1 		$206K Buy
20,800
+800
+4% +$7.89K ﹤0.01% 5062
2021
Q4 		$198K Hold
20,000
– – ﹤0.01% 5343
2021
Q3 		$196K Hold
20,000
– – ﹤0.01% 5196
2021
Q2 		$202K Buy
+20,000
New +$202K ﹤0.01% 5061

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royal Bank of Canada's PROK Position: Q1 2026 in Review

Royal Bank of Canada reduced its ProKidney (PROK) stake by 82% in Q1 2026, selling an estimated $1.88K and leaving 190 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7556.

Royal Bank of Canada first reported a position in PROK in Q2 2021 and has held it in 20 quarters since. The position peaked at $356K in Q3 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Royal Bank of Canada held 190 shares of ProKidney worth $0 as of Q1 2026.
  • Royal Bank of Canada sold 887 ProKidney shares in Q1 2026, an estimated $1.88K.
  • ProKidney made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7556 holding.
  • Royal Bank of Canada first reported a position in ProKidney in Q2 2021 and has held it in 20 quarters since.
  • Royal Bank of Canada's ProKidney position peaked at $356K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.